Allogene Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts that cover Allogene Therapeutics stock have a consensus rating of "Buy" and an average price target of $8.40, which forecasts a 244.26% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $14.

Price Target: $8.40 (+244.26%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$8.40	$9.00	$14
Change	+63.93%	+244.26%	+268.85%	+473.77%

Analyst Ratings

The average analyst rating for Allogene Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	4	4	4	5	5	4
Buy	6	6	6	6	6	6
Hold	1	1	1	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	12	12	12	12	12	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
John Newman Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $14	Strong Buy	Maintains	$14	+473.77%	Mar 13, 2026
Biren Amin Piper Sandler	Piper Sandler	Buy Maintains $7 → $8	Buy	Maintains	$7 → $8	+227.87%	Mar 13, 2026
Reni Benjamin Citizens	Citizens	Hold → Buy Upgrades $5	Hold → Buy	Upgrades	$5	+104.92%	Jan 9, 2026
Michael Yee UBS	UBS	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+227.87%	Jan 7, 2026
Brian Cheng JP Morgan	JP Morgan	Hold → Sell Downgrades n/a	Hold → Sell	Downgrades	n/a	n/a	Oct 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

18.54K

Revenue Next Year

26.15M

from 18.54K

140,929.79%

from 18.54K

EPS This Year

-0.89

from -0.87

EPS Next Year

-0.82

from -0.89

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	114.09M	156.00K	95.00K	22.00K	-	18.54K	26.15M
Revenue Growth	-	-99.86%	-39.10%	-76.84%	-	-	140,929.79%
EPS	-1.34	-2.38	-2.09	-1.32	-0.87	-0.89	-0.82
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	105,000	147.2M
Avg	18,544	26.2M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	793,812.7%
Avg	-	140,929.8%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.45	-0.29
Avg	-0.89	-0.82
Low	-1.44	-1.48

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.